Board of Directors

Strong committed leadership focused on advancing the future of pain management

Kalman Kaufman

Chairman of the Board

Mr. Kaufman served as Corporate Vice President of Applied Materials Previously Mr. Kaufman was the founder and President of KLA Instruments Israel, and General Manager of Kulicke and Soffa Israel. Currently, he serves as chairman and director of several high-tech companies. Mr. Kaufman holds engineering degrees from the Technion – Israel Institute of Technology.

Dennis Crowley

Board Member

Dennis Crowley is senior vice president, Business Development & Licensing at Baxter International Inc. Mr. Crowley joined Baxter in 2017 from Acelity L.P., where he served as senior vice president, Strategy and Business Development....

Previously, he worked at Medtronic plc (and before that, Covidien plc) in roles of increasing responsibility between 2005 and 2015, most recently as vice president, Corporate Development. Mr. Crowley began his professional career with Tyco Healthcare in 1993 and served in various strategic, business development and operational roles during his 12-year tenure. He received his bachelor’s degree in economics from Harvard College.

Dr. Alan Levy

Board Member

Dr. Levy brings to Medasense over forty years of experience in the medical device industry. He spent twenty years at Johnson & Johnson developing many successful medical products and served in numerous leadership roles....

He then established and led multiple medical device companies, including Heartstream, that developed the first small, lightweight and easy-to-use automated external defibrillator.

Dr. Levy has also served as a Senior Advisor at Frazier Healthcare Ventures. He currently serves on the boards of multiple private and public healthcare companies.

Dr. Levy holds a BSc in Chemistry from City College of New York and a PhD and Honorary DSc from Purdue University.

Henry Weinstein

Board Member

Mr. Weinstein has more than eight years' experience as executive and investor in the life sciences industry. He most recently served as Vice President of Innovation and Development at Abbott Laboratories. Prior to that he was Vice President of Strategy and Innovation at CFR Pharmaceuticals....

He has a proven track record of launching over 300 products in the pharmaceutical industry in Latin America and completing more than 20 licensing deals including biotech products and medical devices. He currently serves as a Board Member of Convexity Scientific, Via Surgical and Dog Parker. He previously served on the board of BMRC, a biotech research consortium in Chile.

Manor Zemer

Board Member

Manor Zemer has 20 years of experience in venture capital, financing, private equity and investment banking. He has lived and worked in Israel, China and Europe. Manor is a Partner at Olive Tree Ventures, a digital health venture capital fund that focuses on Israel and Israel-related companies....

Prior to joining Olive Tree Ventures, Manor was a Managing Director at ZZ Capital International (HKG:8295), an alternative investment firm with activities in China, North America, Europe and Israel. Manor was a Managing Director and Head of Capital Markets at Discount Capital, where he founded and led the firm’s investment banking activity in East Asia. Manor spent 8 years in China as an Executive Director for Sage Capital Global, a London-based private equity fund where he successfully completed deals in China and Hong Kong with a total deal value amounting to more than $700 million.

Galit Zuckerman Stark

Founder, CEO and board member

Ms. Zuckerman Stark brings to Medasense over fifteen years of entrepreneurship, management and engineering experience in both start-ups and large corporations. Ms. Zuckerman Stark founded Medasense upon discovering that while advanced algorithms are used frequently in many different industries such as semiconductors, communication, and many others, the discipline of medicine and specifically pain was still left behind....

Before founding Medasense she led a team of algorithm engineers at Applied Materials and worked at Nokia-Siemens and Nice Systems. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.

Ms. Zuckerman Stark holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.

Dr. Shmuel Cabilly

Board Observer

Dr. Cabilly is an investor and a board member of several companies. Dr. Cabilly developed a new technology for recombinant antibody production during a post-doctoral fellow at Genentech. This invention was patented in world patents known as “The Old Cabilly” and “The New Cabilly" patents....

Today there are already twenty drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more. Dr. Cabilly was also a co-founder and a chief scientist of Ethrog Biotechnology where he invented major technologies in the field of chemistry.

Robert Gavshon

Board Observer

Mr. Gavshon migrated to Australia from South Africa in 1978 where he was a partner in one of the largest law firms in that country. In Australia, initially he acted as Group General Counsel and Director of Corporate Affairs with worldwide responsibility for a multinational corporation based in Sydney....

Mr. Gavshon was a significant shareholder in, and served as an Executive Director of private and listed companies which developed icon brands. He has gained broad business experience in Australasia, USA and Asia and has been involved in a number of successful equity ventures where he has also taken Board and advisory roles.

Mr. Gavshon is widely respected for the extensive community service he has given and occupied leading positions in the Australian not-for-profit sector. He holds commerce and law degrees from the University of Witwatersrand, South Africa.